A Brief Sketch of Gene Therapy Vectors and Delivery Methods
Gene therapy is the technique of introducing a healthy gene into a defective cell and help improve a disease condition. The field holds much promise as it seeks to cure …
Read MoreThe Next Generation Biotech Media
Gene therapy is the technique of introducing a healthy gene into a defective cell and help improve a disease condition. The field holds much promise as it seeks to cure …
Read MoreThe cell and gene therapy market was estimated at around 2.6 billion in 2020 and was projected to reach about 25 billion in 2027 with a CAGR of 33.82%, making …
Read MoreIn the race to develop the first gene therapy for hemophilia B, uniQure faced a major roadblock late last year when the FDA put a clinical hold on its HOPE-B …
Read MoreThree years ago, the FDA granted landmark approval to the first in vivo gene therapy for treating an inherited eye disease. Luxturna, an AAV2 based gene therapy developed by Spark …
Read MoreGene therapy is a hot commodity in the biopharma business, attracting profitable investments and expensive M&A transactions in recent years. Moreover, the frequent reports of research breakthroughs and clinical trial …
Read MoreStrideBio, an emerging gene therapy startup, announced on March 16th that the company is setting itself up for exponential growth after closing on a Series B $81.5 million round of …
Read MoreOn March 1st, Tenaya Therapeutics, a San Francisco-based biotech, announced its $106 million Series C funding. The company aims to deliver curative therapies that address the underlying causes of heart …
Read MoreSalioGen Therapeutics, a Burlington-based biotech startup, announced on March 1st that it had closed its $20 million Series A financing round. The funds will support preclinical validation of mammal-derived enzyme …
Read MoreAfter remaining in stealth mode in the past year, Jaguar Gene Therapy and its ciliopathy-focused subsidiary Axovia Therapeutics has launched itself with a Series A to develop adeno-associated virus serotype …
Read MoreOn February 23, Munich-based SIRION Biotech GmbH announced signing a license and collaboration agreement with Sanofi. The agreement intends to harness SIRION’s capabilities as a leader in viral vector-based gene …
Read More